Next Generation Postprocessing Software Receives FDA Clearance

A new magnetic resonance (MR) advanced visualization platform has been designed to help clinicians process and analyze images anytime and anywhere.

GE Healthcare (Chalfont St. Giles, UK) announced US Food and Drug Administration (FDA) clearance of Ready View software. Part of the Dexus workflow, Ready View is accessible through any personal computer (PC), picture archiving and communication system (PACS), or radiology information system (RIS) workstation, allowing access to process and analyze images in any office, meeting room or even at home.

The Ready View advanced visualization platform provides a combination of protocols, applications, and advanced tools that enable a fast, easy, and quantified analysis. In addition to standard and advanced protocols, such as four-dimensional (4D) review and image averaging, Ready View offers fast and accurate multiparametric protocols, such as brain oncology, knee, and liver. Multiparametric protocols offer a new, simple, and intuitive workflow to process all functional data from a single screen without having to leave a reading station.

"MR is moving to quantitative analysis to improve lesion detection, characterization, or monitoring," said Jim Davis, general manager, global MR business GE Healthcare. "The Ready View platform is the first step in bringing clinicians a fast and easy way to process and analyze MR data anytime and anywhere. With Ready View, clinicians can automatically segment an abnormality, convert into a 3D volume, then quickly see, and export the curve and associated statistics to the segmented area. "

Combining Ready View's accessibility with its many productivity tools such as autoprocessing, save state, one-click motion correction, and real time thresholding and segmentation, the software will not only help streamline image processing and analysis but help clinicians provide an effective diagnosis.

Related Links:
GE Healthcare